Table 4 The diagnosis, staging and other information about PTC patients in the training set.
From: Discovery and identification of potential biomarkers of papillary thyroid carcinoma
Patient ID | Age (years) | Sex (F = female M = male) | Diagnosis | Stage | Tumor size (cm) | Cervial lymph node metastasis | Distant metastases |
|---|---|---|---|---|---|---|---|
Patients<45 years | Â | Â | Â | Â | Â | Â | Â |
P38 | 23.01 | F | PTC | I | 0.5 | None | NO |
P78 | 29.98 | F | PTC | I | 1.0 | None | NO |
P65 | 32.12 | F | PTC | I | 1.0 | None | NO |
P81 | 36.45 | F | PTC | I | 0.8 | None | NO |
P36 | 38.50 | F | PTC | I | 0.5 | None | NO |
P43 | 39.56 | F | PTC | I | 1.0 | None | NO |
P16 | 40.05 | F | PTC | I | 0.8 | None | NO |
P44 | 40.11 | M | PTC | I | 1.0 | Yes(VI lymph node) | NO |
P37 | 40.25 | F | PTC | I | 1.6 | None | NO |
P5 | 40.36 | F | PTC | I | 1.0 | None | NO |
P18 | 40.50 | M | PTC | I | 0.6 | None | NO |
P80 | 40.81 | M | PTC | I | 0.7 | None | NO |
P93 | 40.90 | F | PTC | I | 1.0 | None | NO |
P67 | 41.00 | F | PTC | I | 1.0 | None | NO |
P46 | 41.08 | F | PTC | I | 1.5 | None | NO |
P9 | 41.10 | M | PTC | I | 1.8 | Yes(VI lymph node) | NO |
P35 | 41.26 | M | PTC | I | 1.0 | None | NO |
P47 | 41.38 | F | PTC | I | 0.8 | None | NO |
P13 | 41.44 | F | PTC | I | 1.0 | None | NO |
P6 | 41.52 | M | PTC | I | 0.6 | None | NO |
P17 | 41.55 | F | PTC | I | 1.5 | Yes(VI lymph node) | NO |
P40 | 41.62 | F | PTC | I | 0.8 | None | NO |
P64 | 41.71 | F | PTC | I | 0.8 | None | NO |
P111 | 41.89 | M | PTC | I | 1.3 | None | NO |
P69 | 42.14 | M | PTC | I | 1.2 | None | NO |
P2 | 42.25 | F | PTC | I | 1.6 | Yes(VI lymph node) | NO |
P12 | 42.36 | F | PTC | I | 0.8 | None | NO |
P7 | 42.56 | F | PTC | I | 0.8 | None | NO |
P4 | 42.73 | M | PTC | I | 0.6 | None | NO |
P49 | 43.20 | F | PTC | I | 1.2 | None | NO |
P8 | 43.66 | M | PTC | I | 1.5 | Yes(VI lymph node) | NO |
P70 | 43.80 | F | PTC | I | 0.7 | None | NO |
P42 | 44.10 | F | PTC | I | 1.5 | None | NO |
P114 | 44.30 | M | PTC | I | 0.8 | None | NO |
P83 | 44.45 | F | PTC | I | 1.3 | None | NO |
P99 | 44.60 | M | PTC | I | 0.6 | None | NO |
Patients>45 years | Â | Â | Â | Â | Â | Â | Â |
P105 | 45.05 | F | PTC | I | 0.8 | None | NO |
P71 | 45.58 | M | PTC | II | 2.5 | None | NO |
P107 | 45.75 | M | PTC | I | 0.7 | None | NO |
P60 | 45.81 | F | PTC | II | 2.5 | None | NO |
P10 | 46.48 | F | PTC | I | 0.8 | None | NO |
P104 | 46.40 | F | PTC | II | 2.3 | None | NO |
P14 | 46.90 | F | PTC | II | 2.5 | None | NO |
P52 | 47.10 | F | PTC | I | 0.7 | None | NO |
P11 | 47.64 | M | PTC | III | 3.5 | Yes(VI lymph node) | NO |
P88 | 47.89 | F | PTC | I | 0.6 | None | NO |
P22 | 48.50 | F | PTC | I | 0.8 | None | NO |
P73 | 48.81 | M | PTC | I | 0.7 | None | NO |
P87 | 49.56 | F | PTC | III | 4.5 | Yes(VI lymph node) | NO |
P100 | 49.89 | F | PTC | II | 2.8 | None | NO |
P25 | 50.25 | F | PTC | III | 3.8 | Yes(VI lymph node) | NO |
P85 | 50.89 | F | PTC | I | 0.7 | None | NO |
P101 | 57.14 | M | PTC | II | 2.5 | None | NO |
P32 | 58.21 | F | PTC | II | 2.3 | None | NO |
P103 | 60.10 | F | PTC | I | 0.8 | None | NO |
P53 | 61.12 | F | PTC | II | 2.5 | None | NO |
P23 | 65.84 | F | PTC | IV | 4.0 | Yes(hibateral) | Yes(pulmonary metastasis) |
P54 | 68.19 | F | PTC | IV | 3.5 | Yes(mediastinal) | Yes(osseous metastasis) |
P24 | 72.31 | F | PTC | III | 3.6 | None | NO |
P63 | 74.98 | F | PTC | IV | 3.5 | Yes(hibateral) | Yes(pulmonary metastasis) |